Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Effectiveness of Routine Sterile Gloving in Blood Culture

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Wan Beom Park, Seoul National University Hospital
ClinicalTrials.gov Identifier:
NCT00973063
First received: September 7, 2009
Last updated: December 3, 2013
Last verified: December 2013
  Purpose

The purpose of this study is to determine whether routine sterile gloving can lower contamination rates in blood culture.


Condition Intervention
Bacteremia
Behavioral: Routine sterile gloving

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Diagnostic
Official Title: Influence of Routine Sterile Gloving on Contamination Rates in Blood Culture

Resource links provided by NLM:


Further study details as provided by Seoul National University Hospital:

Primary Outcome Measures:
  • contamination rate in blood culture [ Time Frame: at the time of identification of organisms ] [ Designated as safety issue: No ]

Enrollment: 1854
Study Start Date: March 2009
Study Completion Date: December 2009
Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: conventional gloving
Experimental: routine sterile gloving Behavioral: Routine sterile gloving
routinely new sterile gloving just before sampling

Detailed Description:

Because contamination during sampling for blood culture may interfere in interpreting the results of blood culture, lowering the contamination rates in blood culture is very important. According to current guideline, routine sterile gloving is not recommended. We hypothesized that routine sterile gloving can lower contamination rates in blood culture.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • The patients in whom Blood culture is medically needed

Exclusion Criteria:

  • Blood sample is obtained through central venous catheter or arterial line
  • No consent to this study
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00973063

Locations
Korea, Republic of
Seoul National University Hospital
Seoul, Korea, Republic of, 110-744
Sponsors and Collaborators
Seoul National University Hospital
Investigators
Principal Investigator: WAN BEOM PARK, MD Seoul National University Hospital
  More Information

No publications provided by Seoul National University Hospital

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Wan Beom Park, Associate Professor, Seoul National University Hospital
ClinicalTrials.gov Identifier: NCT00973063     History of Changes
Other Study ID Numbers: 0906-029-283, SNUHIMI01
Study First Received: September 7, 2009
Last Updated: December 3, 2013
Health Authority: South Korea: Institutional Review Board

Keywords provided by Seoul National University Hospital:
bacteremia
blood culture
contamination

Additional relevant MeSH terms:
Bacteremia
Bacterial Infections
Infection
Inflammation
Pathologic Processes
Sepsis
Systemic Inflammatory Response Syndrome

ClinicalTrials.gov processed this record on November 24, 2014